These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30301768)

  • 1. Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver.
    Habib A; Chokr D; Wan J; Hegde P; Mabire M; Siebert M; Ribeiro-Parenti L; Le Gall M; Lettéron P; Pilard N; Mansouri A; Brouillet A; Tardelli M; Weiss E; Le Faouder P; Guillou H; Cravatt BF; Moreau R; Trauner M; Lotersztajn S
    Gut; 2019 Mar; 68(3):522-532. PubMed ID: 30301768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoacylglycerol lipase reprograms hepatocytes and macrophages to promote liver regeneration.
    Allaire M; Al Sayegh R; Mabire M; Hammoutene A; Siebert M; Caër C; Cadoux M; Wan J; Habib A; Le Gall M; de la Grange P; Guillou H; Postic C; Paradis V; Lotersztajn S; Gilgenkrantz H
    JHEP Rep; 2023 Aug; 5(8):100794. PubMed ID: 37520673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway.
    Denaës T; Lodder J; Chobert MN; Ruiz I; Pawlotsky JM; Lotersztajn S; Teixeira-Clerc F
    Sci Rep; 2016 Jun; 6():28806. PubMed ID: 27346657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of lower urinary tract dysfunction by a monoacylglycerol lipase inhibitor in mice with spinal cord injury.
    Cho KJ; Hashimoto M; Karnup S; Matsuoka K; Kamijo T; Kim JC; Koh JS; Yoshimura N
    Neurourol Urodyn; 2024 Jun; 43(5):1207-1216. PubMed ID: 38533637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.
    Ignatowska-Jankowska B; Wilkerson JL; Mustafa M; Abdullah R; Niphakis M; Wiley JL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2015 May; 353(2):424-32. PubMed ID: 25762694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.
    Wilkerson JL; Niphakis MJ; Grim TW; Mustafa MA; Abdullah RA; Poklis JL; Dewey WL; Akbarali H; Banks ML; Wise LE; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2016 Apr; 357(1):145-56. PubMed ID: 26791602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats.
    Jiang SK; Zhang M; Tian ZL; Wang M; Zhao R; Wang LL; Li SS; Liu M; Li JY; Zhang MZ; Guan DW
    Eur J Pharmacol; 2015 Aug; 761():1-10. PubMed ID: 25912803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
    Cao Z; Mulvihill MM; Mukhopadhyay P; Xu H; Erdélyi K; Hao E; Holovac E; Haskó G; Cravatt BF; Nomura DK; Pacher P
    Gastroenterology; 2013 Apr; 144(4):808-817.e15. PubMed ID: 23295443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke.
    Choi SH; Arai AL; Mou Y; Kang B; Yen CC; Hallenbeck J; Silva AC
    Stroke; 2018 Mar; 49(3):718-726. PubMed ID: 29440474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy.
    Curry ZA; Wilkerson JL; Bagdas D; Kyte SL; Patel N; Donvito G; Mustafa MA; Poklis JL; Niphakis MJ; Hsu KL; Cravatt BF; Gewirtz DA; Damaj MI; Lichtman AH
    J Pharmacol Exp Ther; 2018 Jul; 366(1):169-183. PubMed ID: 29540562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors.
    Niphakis MJ; Cognetta AB; Chang JW; Buczynski MW; Parsons LH; Byrne F; Burston JJ; Chapman V; Cravatt BF
    ACS Chem Neurosci; 2013 Sep; 4(9):1322-32. PubMed ID: 23731016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain.
    Thompson AL; Grenald SA; Ciccone HA; BassiriRad N; Niphakis MJ; Cravatt BF; Largent-Milnes TM; Vanderah TW
    J Pharmacol Exp Ther; 2020 May; 373(2):230-238. PubMed ID: 32054717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Repeated Treatment with the Monoacylglycerol Lipase Inhibitor MJN110 on Pain-Related Depression of Nesting and Cannabinoid 1 Receptor Function in Male and Female Mice.
    Diester CM; Balint H; Gillespie JC; Lichtman AH; Sim-Selley LJ; Selley DE; Negus SS
    J Pharmacol Exp Ther; 2024 Aug; 390(3):291-301. PubMed ID: 38262742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
    Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
    J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage autophagy protects against liver fibrosis in mice.
    Lodder J; Denaës T; Chobert MN; Wan J; El-Benna J; Pawlotsky JM; Lotersztajn S; Teixeira-Clerc F
    Autophagy; 2015; 11(8):1280-92. PubMed ID: 26061908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid System Contributes to Liver Injury and Inflammation by Activation of Bone Marrow-Derived Monocytes/Macrophages in a CB1-Dependent Manner.
    Mai P; Yang L; Tian L; Wang L; Jia S; Zhang Y; Liu X; Yang L; Li L
    J Immunol; 2015 Oct; 195(7):3390-401. PubMed ID: 26320250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver.
    Guillot A; Hamdaoui N; Bizy A; Zoltani K; Souktani R; Zafrani ES; Mallat A; Lotersztajn S; Lafdil F
    Hepatology; 2014 Jan; 59(1):296-306. PubMed ID: 23813495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
    Wen J; Ribeiro R; Tanaka M; Zhang Y
    Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction.
    Schloss MJ; Horckmans M; Guillamat-Prats R; Hering D; Lauer E; Lenglet S; Weber C; Thomas A; Steffens S
    Cardiovasc Res; 2019 Mar; 115(3):602-613. PubMed ID: 30295758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.